The Impact of Preeclampsia in Lupus Nephritis.

Arterial hypertension chronic kidney disease eclampsia lupus flare lupus nephritis preeclampsia systemic lupus erythematosus

Journal

Expert review of clinical immunology
ISSN: 1744-8409
Titre abrégé: Expert Rev Clin Immunol
Pays: England
ID NLM: 101271248

Informations de publication

Date de publication:
10 May 2022
Historique:
pubmed: 6 5 2022
medline: 6 5 2022
entrez: 5 5 2022
Statut: aheadofprint

Résumé

Women with systemic lupus erythematosus (SLE), particularly those with lupus nephritis (LN), remain at high risk for adverse pregnancy outcome. Although in the last decades maternal and fetal outcomes have improved dramatically, preeclampsia remains a major cause of maternal and perinatal morbidity and mortality. A narrative review of literature was conducted, underlying the importance of pre-conception counseling, and focusing on the correlation between preeclampsia and LN. The clinical characteristics of preeclampsia were described, with emphasis on risk factors in LN and the differential diagnosis between preeclampsia and lupus flares. Additionally, the prevention and treatment of preeclampsia were discussed, as well as the management of short-term and long-term consequences of preeclampsia. We highlight the importance of a pre-pregnancy counseling from a multidisciplinary team to plan pregnancy during inactive SLE and LN. Further studies are needed to evaluate the long-term consequences of pregnancy in LN. Considering that preeclamptic patients can be at high risk for long-term renal failure, we suggest renal checkup for at least 6-12 months after delivery in all patients.

Identifiants

pubmed: 35510378
doi: 10.1080/1744666X.2022.2074399
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-13

Auteurs

Gabriella Moroni (G)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy.

Marta Calatroni (M)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy.

Claudio Ponticelli (C)

Independent Researcher, Past Director Nephrology Policlinico, Milan, Italy.

Classifications MeSH